Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 241

Similar articles for PubMed (Select 19224794)


Xenon preconditioning: the role of prosurvival signaling, mitochondrial permeability transition and bioenergetics in rats.

Mio Y, Shim YH, Richards E, Bosnjak ZJ, Pagel PS, Bienengraeber M.

Anesth Analg. 2009 Mar;108(3):858-66. doi: 10.1213/ane.0b013e318192a520.


Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo.

Pagel PS, Krolikowski JG, Shim YH, Venkatapuram S, Kersten JR, Weihrauch D, Warltier DC, Pratt PF Jr.

Anesth Analg. 2007 Sep;105(3):562-9.


Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta.

Feng J, Lucchinetti E, Ahuja P, Pasch T, Perriard JC, Zaugg M.

Anesthesiology. 2005 Nov;103(5):987-95.


Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.

Jeong CW, Yoo KY, Lee SH, Jeong HJ, Lee CS, Kim SJ.

J Cardiovasc Pharmacol Ther. 2012 Dec;17(4):387-94. doi: 10.1177/1074248412438102. Epub 2012 Mar 6.


Intralipid, a clinically safe compound, protects the heart against ischemia-reperfusion injury more efficiently than cyclosporine-A.

Li J, Iorga A, Sharma S, Youn JY, Partow-Navid R, Umar S, Cai H, Rahman S, Eghbali M.

Anesthesiology. 2012 Oct;117(4):836-46.


Age-associated differences in activation of Akt/GSK-3beta signaling pathways and inhibition of mitochondrial permeability transition pore opening in the rat heart.

Zhu J, Rebecchi MJ, Tan M, Glass PS, Brink PR, Liu L.

J Gerontol A Biol Sci Med Sci. 2010 Jun;65(6):611-9. doi: 10.1093/gerona/glq035. Epub 2010 Apr 28.


Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore.

Xi J, Wang H, Mueller RA, Norfleet EA, Xu Z.

Eur J Pharmacol. 2009 Feb 14;604(1-3):111-6. doi: 10.1016/j.ejphar.2008.12.024. Epub 2008 Dec 24.


Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A.

Onishi A, Miyamae M, Kaneda K, Kotani J, Figueredo VM.

Eur J Pharmacol. 2012 Jan 30;675(1-3):40-6. doi: 10.1016/j.ejphar.2011.11.040. Epub 2011 Dec 7.


Induction of autophagy restores the loss of sevoflurane cardiac preconditioning seen with prolonged ischemic insult.

Shiomi M, Miyamae M, Takemura G, Kaneda K, Inamura Y, Onishi A, Koshinuma S, Momota Y, Minami T, Figueredo VM.

Eur J Pharmacol. 2014 Feb 5;724:58-66. doi: 10.1016/j.ejphar.2013.12.027. Epub 2013 Dec 25.


Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3beta.

Chanoit G, Lee S, Xi J, Zhu M, McIntosh RA, Mueller RA, Norfleet EA, Xu Z.

Am J Physiol Heart Circ Physiol. 2008 Sep;295(3):H1227-H1233. doi: 10.1152/ajpheart.00610.2008. Epub 2008 Jul 25.


Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation.

Das S, Wong R, Rajapakse N, Murphy E, Steenbergen C.

Circ Res. 2008 Oct 24;103(9):983-91. doi: 10.1161/CIRCRESAHA.108.178970. Epub 2008 Sep 18.


Sevoflurane confers additive cardioprotection to ethanol preconditioning associated with enhanced phosphorylation of glycogen synthase kinase-3β and inhibition of mitochondrial permeability transition pore opening.

Onishi A, Miyamae M, Inoue H, Kaneda K, Okusa C, Inamura Y, Shiomi M, Koshinuma S, Momota Y, Figueredo VM.

J Cardiothorac Vasc Anesth. 2013 Oct;27(5):916-24. doi: 10.1053/j.jvca.2012.10.002. Epub 2012 Dec 23.


Myocardial reperfusion injury management: erythropoietin compared with postconditioning.

Tamareille S, Ghaboura N, Treguer F, Khachman D, Croué A, Henrion D, Furber A, Prunier F.

Am J Physiol Heart Circ Physiol. 2009 Dec;297(6):H2035-43. doi: 10.1152/ajpheart.00472.2009. Epub 2009 Jul 17. Erratum in: Am J Physiol Heart Circ Physiol. 2009 Dec;297:H2035.


Helium-induced early preconditioning and postconditioning are abolished in obese Zucker rats in vivo.

Huhn R, Heinen A, Weber NC, Kerindongo RP, Oei GT, Hollmann MW, Schlack W, Preckel B.

J Pharmacol Exp Ther. 2009 May;329(2):600-7. doi: 10.1124/jpet.108.149971. Epub 2009 Feb 25.


Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation.

Clarke SJ, Khaliulin I, Das M, Parker JE, Heesom KJ, Halestrap AP.

Circ Res. 2008 May 9;102(9):1082-90. doi: 10.1161/CIRCRESAHA.107.167072. Epub 2008 Mar 20.


Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition.

Miki T, Miura T, Hotta H, Tanno M, Yano T, Sato T, Terashima Y, Takada A, Ishikawa S, Shimamoto K.

Diabetes. 2009 Dec;58(12):2863-72. doi: 10.2337/db09-0158. Epub 2009 Sep 15.


Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore.

Obame FN, Plin-Mercier C, Assaly R, Zini R, Dubois-Randé JL, Berdeaux A, Morin D.

J Pharmacol Exp Ther. 2008 Jul;326(1):252-8. doi: 10.1124/jpet.108.138008. Epub 2008 Apr 23.


Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: role of cyclooxygenase-2.

Tanaka K, Ludwig LM, Krolikowski JG, Alcindor D, Pratt PF, Kersten JR, Pagel PS, Warltier DC.

Anesthesiology. 2004 Mar;100(3):525-31.


The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK.

Weber NC, Toma O, Wolter JI, Obal D, Müllenheim J, Preckel B, Schlack W.

Br J Pharmacol. 2005 Jan;144(1):123-32.


Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.

Ghaboura N, Tamareille S, Ducluzeau PH, Grimaud L, Loufrani L, Croué A, Tourmen Y, Henrion D, Furber A, Prunier F.

Basic Res Cardiol. 2011 Jan;106(1):147-62. doi: 10.1007/s00395-010-0130-3. Epub 2010 Oct 28.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk